Navigation Links
Preventing Osteoporosis

Osteoporosis is a chronic, progressive disorder where there is a loss of normal bone density. A new study shows that the drug // alendronate if taken daily for 10 years can increase bone density in postmenopausal women. Drugs, such as alendronate, have been used for years to treat osteoporosis.

The research began with a three-year study on women taking the drug or a placebo. Women on the drug continued to receive the drug for the next two years. Then for the next five years, women on 5 milligrams or 10 milligrams of the drug continued with the drug at the same dose, while another group of women received 20 milligrams of the drug for two years. That was followed by 5 milligrams of the drug for three years and then a placebo for the next five years. Researchers say 247 women stayed with the study for the entire 10 years.

The study showed women on 10 milligrams of alendronate daily increased their bone density compared to women not on the drug. Women on 5 milligrams had smaller gains than women on 10 milligrams. In addition, researchers say women who were on the drug and then taken off of it had a gradual loss of their improvements in their bone density.

Thus researchers say continuous treatment of 10 milligrams of alendronate appears to be the best treatment for postmenopausal women and the key is staying on the drug because once you go off of it the benefits start to diminish.
'"/>




Page: 1

Related medicine news :

1. Preventing mental decline in the aged
2. Preventing white coat hypertension
3. Preventing Childhood Deaths
4. Preventing Vision Loss
5. Preventing Vision Loss
6. Preventing Colorectal Cancer
7. Preventing Prostate Cancer
8. Lycopene Can Help In Preventing Prostate Cancer
9. Heart Drug Also Effective In Preventing Specific Causes Of Death
10. Preventing cavities in children
11. Preventing Strokes Using Less Invasive Techniques
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Preventing Osteoporosis

(Date:12/2/2008)... DETROIT, Dec. 2 United ..., which owns and provides comprehensive healthcare...on in Tennessee, today,announced that its Board o...m,authorizing the Company to repurchase up to $1... The program allows for the Company,s common sh...
(Date:12/2/2008)... NEW YORK, Dec. 2 Today...om across the country are coming together at Liz,...or Education to Stop Teen,Dating Abuse. Ann and C...urke,who was murdered by her abusive ex-boyfriend... Redbook magazine on this national coalition that ...
(Date:12/2/2008)... PHILADELPHIA, Dec. 2 Un...vania children the opportunity to become "health,...designing programs to,address it and implementing...dHealth HEROES is a service-learning, health liter..., working through educators and youth,leaders, to...
(Date:12/2/2008)... But too few patients are having the procedure, st...News) -- People with the most common form of epile...ve years of life, and dramatically improved qualit...rain surgery. , That,s the finding of a new stu...benefits of surgery of the temporal lobe region fo...
Breaking Medicine News(10 mins):Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3
...e monitoring device for patients is changing the w...lanted defibrillators//. Rush University Medical ...TITUDE? Patient Management system to determine if ...decrease hospitalizations for heart failure. A mi...
...idly among the rich and educated class in South Af...arkinor Polling// company along with the Universit...aid to be a disease of the poor but it has spread ...gher strata of society too. The reasons cited are ...
...al Health Interview Survey (NHIS) suggest that at ...r scaly skin during the winter months// due to bla...over-heated homes and offices. “Winter is no frie... says Rebecca A. Kazin, M.D., assistant professor ...
...ock Holmes to the hilt when he discovered a link b...ey were using//, and in turn provided material for...pediatric endocrinologist at the University of Col...mother when she brought a her 4 year old son to ge...
Other Medicine News:Health News:Remote Device to Monitor Patients Daily at Their Homes 2Health News:Breast Growth in Boys and Herb Based Products-probable Link, Say Scientists 2
(Date:12/1/2008)...IEGO, Dec. 1 TargeGen has announce...ts from a multi-center, US-based clinical,trial o...has been scheduled at,the 2008 American Society o...the presentation are as follows:, Title: ...ioavailable, JAK2-Selectiv...
(Date:12/1/2008)...Girl with Hypophosphatasia Treated With ENB-0040 a...innipeg , , MONTREAL, Dec. 1 /PRNewswire/ -...any focused on developing novel therapeutics for s...rst infant patient in its clinical program for hyp...nzyme Replacement Therapy (ERT) with ENB-0040 for ...
(Date:12/1/2008)...UTH MEETING, Pa., Dec. 1 ...unced that dosing of subjects has begun in study M...ose Phase 1b study of trodusquemine (MSI-1436) in ... a novel therapeutic for the treatment of type 2 d...pherally to regulate insulin and leptin pathways t...
(Date:12/1/2008)...TA, Dec. 1 GeoVax Labs, ... biotechnology company developing,human vaccines ...cy Virus) and,other infectious agents, announced ...ne Trials will take place in twelve sites across N...d in collaboration with The National Institutes of...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Iomai Stockholders Approve Merger With Intercell Subsidiary 6882 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 1Immune system protein accurate predictor of survival in pediatric septic shock 4305 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 3Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 1Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 2Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 3Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 4
....--(BUSINESS WIRE)--Jul 5, 2007 - GTC,Biotherapeut...at,Geoffrey Cox, Ph.D., GTC,s Chairman and CEO, is...at 9:00 a.m. during the C.E.,Unterberg, Towbin Eme...nference is being held at the Mandarin Oriental Ho...The presentation will be webcast live and can be a...
...--(BUSINESS WIRE)--Jul 3, 2007 - EPIX,Pharmaceutic...el G.,Kauffman, M.D., Ph.D., chief executive offic...terberg, Towbin Emerging Growth,Opportunities Conf...) at the Mandarin Oriental Hotel in New York, NY.,...accessed on the,EPIX website, www.epixpharma.com, ...
Other Medicine Technology:GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.,Unterberg, Towbin Emerging Growth Life Opportunities Conference 2EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference 2
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; C-Flex
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: